{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"dataset_type":["N/A"],"submitter_keywords":["COVID-19","SARS-CoV-2","2019 novel coronavirus infection","2019-nCoV infection","severe acute respiratory syndrome coronavirus 2","coronavirus disease 2019","SARS-coronavirus 2"],"full_dataset_link":["https://ega-archive.org/datasets/EGAD00001006339"],"sample_count":["36"],"description":["EGA dataset EGAD00001006339"],"repository":["EGA"],"title":["COVID-19 severity correlates with airway epitheliumÃ¢Â€Â“immune cell interactions identified by single-cell analysis"],"pubmed_abstract":["To investigate the immune response and mechanisms associated with severe coronavirus disease 2019 (COVID-19), we performed single-cell RNA sequencing on nasopharyngeal and bronchial samples from 19 clinically well-characterized patients with moderate or critical disease and from five healthy controls. We identified airway epithelial cell types and states vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In patients with COVID-19, epithelial cells showed an average three-fold increase in expression of the SARS-CoV-2 entry receptor ACE2, which correlated with interferon signals by immune cells. Compared to moderate cases, critical cases exhibited stronger interactions between epithelial and immune cells, as indicated by ligand-receptor expression profiles, and activated immune cells, including inflammatory macrophages expressing CCL2, CCL3, CCL20, CXCL1, CXCL3, CXCL10, IL8, IL1B and TNF. The transcriptional differences in critical cases compared to moderate cases likely contribute to clinical observations of heightened inflammatory tissue damage, lung injury and respiratory failure. Our data suggest that pharmacologic inhibition of the CCR1 and/or CCR5 pathways might suppress immune hyperactivation in critical COVID-19."],"pubmed_title":["COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis."],"pubmed_authors":["Chua Robert Lorenz RL, Lukassen Soeren S, Trump Saskia S, Hennig Bianca P BP, Wendisch Daniel D, Pott Fabian F, Debnath Olivia O, Thürmann Loreen L, Kurth Florian F, Völker Maria Theresa MT, Kazmierski Julia J, Timmermann Bernd B, Twardziok Sven S, Schneider Stefan S, Machleidt Felix F, Müller-Redetzky Holger H, Maier Melanie M, Krannich Alexander A, Schmidt Sein S, Balzer Felix F, Liebig Johannes J, Loske Jennifer J, Suttorp Norbert N, Eils Jürgen J, Ishaque Naveed N, Liebert Uwe Gerd UG, von Kalle Christof C, Hocke Andreas A, Witzenrath Martin M, Goffinet Christine C, Drosten Christian C, Laudi Sven S, Lehmann Irina I, Conrad Christian C, Sander Leif-Erik LE, Eils Roland R"],"name_synonyms":["Vasp, VASP, Data Set., DmelCG15112, ENHANCER OF ATNSI ACTIVITY, MENA, NDPP1, l(2)02029, Enb, enb, ENA, Ena, CG15112, ENA/VASP"],"description_synonyms":["GROg, Granulocyte, LYNAP, CHEMR13, SCYAR1, Granulocyte Chemotactic Peptide Interleukin 8, HSMCR30, Virus Infection, LD78alpha, Glandular, MIP-1alpha, MCAF, MAGE-E1 antigen, dmTAF[[II]]230, T22F8_160, Chemokine, GRP8, Monocyte-Derived Neutrophil Chemotactic Factor, GROa, average, SCYB10, E-Cigarette or Vaping Product Use-Associated Lung Injury, TFIID TAF250, cel, CG12919, Coronavirus Disease 2019, Tissue, C7, Hypoxemic Respiratory Failure, IDDM22, Adenomatous Epithelial, X, beta-CoVs, ACEH, Acute Hypoxemic Respiratory Failure, DIF, MDNCF, TNFSF2, Homo sapiens disease, Infections and Infestations, MONAP, HC11, COVID 19 Virus Disease, EVALIs, 2019-nCoV Infections, dif, tnfa, dTAF[[II]]230, Ligand, SARS-CoV-2 Viruses, β-CoV, 2019-nCoV Infections., SARS-CoV-2, TAF200, TNFA, CKR5, Alveolar Macrophage Chemotactic Factor-I, Coronavirus 2, Squamous, CKR1, 2019 nCoV Infection, COVID 19 Virus Infection, ST38, Anionic Neutrophil-Activating Peptide, CC-CKR-5, SARS-CoV-2 Virus, Ckr5, IP-10, CC-CKR-1, Regg1, DAMAGE, Hepatocellular carcinoma-associated protein 1, IL1F2, E-Cigarette Use-Associated Lung Injury, simple tissue, Neutrophil Chemotactic Factor, Monocyte-Derived Macrophages, GLYCINE-RICH PROTEIN 8, MCP-1, CD195, Adenomatous Epithelial Cells, GRO, CD191, Pandemic, AMCF-I, Neutrophil Activation Factor, Infection and Infestation, crg-2, EVALI, gro, Taf250, SCYA20, Cells, 2019, NAF, Tnfa, 2019-nCoV Diseases, Macrophage inflammatory protein 1-alpha receptor, TAF230, Alveolar Macrophage Chemotactic Factor I, Pulmonary Injury, Lung, Dcip1, TNF, COVID-19, Hypoxemic Acute Respiratory Failure, Scyb1, SARS CoV 2 Virus, COVID19 Virus, Respiratory Failures, and RNA binding 1, CXCL8 Chemokine, Fsp, FSP, E Cigarette Use Associated Lung Injury, SARS, IL1-BETA, Severe Acute Respiratory Syndrome Coronavirus 2 Infection, disease or disorder, β-coronavirus, 2019-nCoV, JE, Pulmonary, SARS Coronavirus 2, β-CoVs, Injury, C-C CKR-5, dTAF[[II]]250, SCYB1, C-C CKR-1, SCYB3, cell, MGSA, ligand, MIP-3-alpha, RATTNF, COVID-19 Virus Infection, Hypoxemic Respiratory, severe acute respiratory syndrome coronavirus 2, Bone Marrow-Derived Macrophage, MIP-1alpha-R, KC, AI847422, SARS-CoV-2 Infection, Crg2, clinical infection, Je, DmelCG12919, Bone Marrow-Derived, dTAF250, COVID-19 Virus, darth, SCYA3, ATGRP8, Transitional Epithelial Cells, SCYA2, Sigje, Chronic, Scya2, Scya3, Transitional, Squamous Cells, Coronavirus Disease 19, Hypoxemic Respiratory Failures, 2019 Novel Coronavirus, beta-CoV, xtnf, disorders, Chronic Lung Injury, BG:DS00004.13, SARS-CoV-2 Infections, Granulocyte Chemotactic Peptide-Interleukin-8, Lymphocyte-Derived Neutrophil-Activating Peptide, Cell, dTAF230, dt1, COVID-19 Virus Disease, Cmkbr5, IP10, Monocyte-Derived, Severe Acute Respiratory Syndrome Coronavirus 2, Cmkbr1, Cuboidal Glandular Epithelial Cells, Mgsa, weche, Ventilatory, TAF[[II]]250/230, condition, Columnar Glandular Epithelial Cells, AI323594, epitheliocyte, Macrophage, Taf[[II]]250, 2019 Novel, betacoronavirus, RGD1560259, Macrophages, IFI10, Monocyte-Derived Neutrophil-Activating Peptide, GR-RBP8, MCP1, COVID-19 Pandemics, COVID-19 Pandemic, CINC-2b, Ifi10, T24D18_5, IRX4, Anionic Neutrophil-Activating, Bone Marrow-Derived Macrophages, Macrophage Derived, Severe, COVID 19, T22F8.160, Epithelial Cell, Exodus, Scyb15, Infestations and Infections, Lymphocyte-Derived, Acute Hypercapnic Respiratory Failure, 2019 novel coronavirus, Scyb10, Virus Disease, 2019 nCoV Disease, IL-1, diseases, Neutrophil-Activating Peptide, ATCRR1, 2019-nCoV Disease, IL-8, Novel Coronavirus, Monocyte-Derived Macrophage, Virus, diseases and disorders, xtnf-alpha, COVID 19 Pandemic, MIP-1-alpha, CXCL8 Chemokines, Immune Processes, Immune Responses, human disease, LARC, MGSA-a, regg1, MIP1-alpha, Coronavirus Disease-19, Lung Injury, LD78ALPHA, acute and chronic respiratory failure, lungkine, il1b-A, CCR1, CKb4, Immune, HCA1, Respiratory, Macrophage-Derived Chemotactic Factor, Hypercapnic Acute Respiratory Failure, glycine-rich RNA-binding protein 8, SMC-CF, respiratory epithelial cell, Transitional Epithelial Cell, AM4-7, Process, CRG-2, COVID-19 Viruses, Adenomatous, Lung Injuries, RNA-seq, mob-1, 2019 Novel Coronavirus Disease, ATCCR1, TAFII-250, TAF250/230, Transitional Epithelial, CCR5, GDCF-2, PAS14, COVID19 Viruses, TAFII250, epithelial, Diseases, tnf-alpha, Coronavirus, COVID-19 Virus Infections, MIP1aR, Adenomatous Epithelial Cell, Squamous Cell, Anionic Neutrophil Activating Peptide, RANTES-R, cold, Coronavirus Disease 2019 Virus, CCCKR5, Anionic, Hypoxemic, Chemotactic Factor, CCR-5, TNFalpha, Mip-1a-R, BcDNA:RH51659, CCR-1, CG17603, TAF[[II]], cinnamoyl coa reductase 1, disease, Patient, SR3-5, NAP1, 2019 Novel Coronavirus Infection, Chemotactic Peptide-Interleukin-8, Interferon, mMage-e1, HIV-1 fusion coreceptor, Chemokines, COVID19, other disease, INP10, d230, TNF-alpha, MIP-1a, NAP-1, Hypercapnic Respiratory, NAP-3, Monocyte Derived Macrophages, COVID-19 Virus Diseases, dTAFII250, Lymphocyte Derived, Glandular Epithelial, circadian rhythm, EfW1, G0S19-1, Failure, TNF-a, CAT1, Depressions, Squamous Epithelial Cells, MIP-2b, Vaping Product Use Associated Lung Injury, dmTAF1, Taf230, Il-1b, Ventilatory Depression, SARS CoV 2 Infection, Whole Transcriptome Shotgun Sequencing, Chronic Lung Injuries, E Cigarette or Vaping Product Use Associated Lung Injury, Squamous Epithelial, MIP1A, IL-1B, TAF250, 2019 Novel Coronaviruses, Epithelial, Taf200, HAF3, Viruses, MIP-3a, Respiratory Failure, IL-1beta, Wuhan Seafood Market Pneumonia Virus, chronic respiratory failure, Il8, Taf1p, HM145, 2010305L05Rik, Ect1, Interleukin 8, non-neoplastic, Chemokine CXCL8, Infestation and Infection, Immune Response, Epithelial Cells, N51, Clients, MIP1-(a), UNQ868/PRO1885, Vaping Product Use-Associated Lung Injury, disorder, IL8, TAF, Immune Process, Squamous Epithelial Cell, SARS Coronavirus 2 Infection, Neutrophil, Glandular Epithelial Cell, Wuhan Coronavirus, AI323804, CXCL8, Disease, TAF[[II]]250, LD78 receptor, LECT, CINNAMOYL COA REDUCTASE, GCP-1, Alpha-dystrobrevin-associated MAGE Protein, CMKBR5, gIP-10, ggr, Hypercapnic, l(3)84Ab, CRINKLY4 related 1, CMKBR1, medical condition, Monocyte Derived, LUCT, Client, GCP1, Peptide, 2019-nCoV Infection, tnfsf2, p230, acute-on-chronic respiratory failure, Infection, Neutrophil Activating Peptide, TFIID, IRREGULAR XYLEM 4, CKR-5, Disease 2019, TAF[[II]]230, airway epithelial cell, Gro1, GRO1, Macrophage-Derived, GRO3, Pulmonary Injuries, Hypercapnic Respiratory Failures, Glandular Epithelial Cells, acute respiratory failure, Bone Marrow Derived Macrophages, GLC2, TAF[II]250, Wuhan, Gm1960, SPBC365.17, MIP2B, GROA, CKR-1, SARS-coronavirus 2, Injuries, Respiratory Depression, DmelCG17603, Mip1a, Response, Egr, Hypercapnic Respiratory Failure, COVID 19 Virus, T24D18.5, Tnfsf1a, MIP3A, TAF1"],"pubmed_title_synonyms":["epithelial tissue of respiratory tract, COVID19, Disease, Coronavirus Disease 19, β-CoV, airway epithelium, immune cell, beta-CoV, respiratory epithelium, respiratory tract epithelial tissue, COVID-19, Single-Cell Analyses, SARS-CoV-2, Virus Infection, COVID-19 Virus Diseases, 2019 novel coronavirus, 2019 Novel Coronavirus Disease, SARS-CoV-2 Infections, PMN cell, 2019 nCoV Infection, COVID 19 Virus Infection, Virus Disease, Single-Cell, 2019 nCoV Disease, COVID-19 Virus Disease, 2019-nCoV Infection, 2019-nCoV Disease, SARS CoV 2 Infection, Infection, Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Coronavirus, COVID-19 Virus Infections, β-coronavirus, Analysis, 2019-nCoV, COVID 19 Pandemic, Single-Cell., Single Cell Analysis, β-CoVs, leucocyte, betacoronavirus, Disease 2019, Pandemic, Analyses, COVID-19 Virus Infection, Coronavirus Disease 2019, severe acute respiratory syndrome coronavirus 2, Coronavirus Disease-19, PMNC, COVID-19 Pandemics, SARS-CoV-2 Infection, COVID-19 Pandemic, beta-CoVs, SARS-coronavirus 2, COVID-19 Virus, white blood cell, epithelium of respiratory tract, 2019 Novel Coronavirus Infection, 2019-nCoV Diseases, COVID 19 Virus Disease, SARS Coronavirus 2 Infection, COVID 19, polymorphonuclear cell, 2019-nCoV Infections"],"pubmed_abstract_synonyms":["Granulocyte, LYNAP, RNA Sequence Determination, CHEMR13, Ass-1, SCYAR1, Sequence Determination, RNA Sequence, Granulocyte Chemotactic Peptide Interleukin 8, HSMCR30, Virus Infection, LD78alpha, Glandular, MIP-1alpha, MCAF, MAGE-E1 antigen, dmTAF[[II]]230, T22F8_160, Chemokine, fold, GRP8, Analysis, Monocyte-Derived Neutrophil Chemotactic Factor, average, SCYB10, E-Cigarette or Vaping Product Use-Associated Lung Injury, TFIID TAF250, Analyses, cel, CG12919, Coronavirus Disease 2019, Tissue, C7, Hypoxemic Respiratory Failure, IDDM22, Adenomatous Epithelial, X, beta-CoVs, Sequence Determinations, ACEH, Acute Hypoxemic Respiratory Failure, DIF, MDNCF, TNFSF2, Homo sapiens disease, Infections and Infestations, MONAP, HC11, COVID 19 Virus Disease, EVALIs, 2019-nCoV Infections, dif, tnfa, dTAF[[II]]230, Ligand, SARS-CoV-2 Viruses, β-CoV, 2019-nCoV Infections., SARS-CoV-2, TAF200, TNFA, CKR5, Alveolar Macrophage Chemotactic Factor-I, Coronavirus 2, Squamous, CKR1, 2019 nCoV Infection, COVID 19 Virus Infection, ST38, Anionic Neutrophil-Activating Peptide, CC-CKR-5, SARS-CoV-2 Virus, Ckr5, IP-10, CC-CKR-1, Regg1, DAMAGE, Hepatocellular carcinoma-associated protein 1, IL1F2, E-Cigarette Use-Associated Lung Injury, simple tissue, Neutrophil Chemotactic Factor, Monocyte-Derived Macrophages, GLYCINE-RICH PROTEIN 8, MCP-1, CD195, Adenomatous Epithelial Cells, CD191, Pandemic, AMCF-I, Neutrophil Activation Factor, Infection and Infestation, crg-2, EVALI, Taf250, SCYA20, Cells, 2019, NAF, Tnfa, 2019-nCoV Diseases, Macrophage inflammatory protein 1-alpha receptor, TAF230, Alveolar Macrophage Chemotactic Factor I, Pulmonary Injury, Lung, TNF, COVID-19, Hypoxemic Acute Respiratory Failure, SARS CoV 2 Virus, COVID19 Virus, Respiratory Failures, and RNA binding 1, CXCL8 Chemokine, E Cigarette Use Associated Lung Injury, SARS, IL1-BETA, Severe Acute Respiratory Syndrome Coronavirus 2 Infection, disease or disorder, β-coronavirus, 2019-nCoV, JE, Pulmonary, SARS Coronavirus 2, β-CoVs, Injury, C-C CKR-5, dTAF[[II]]250, C-C CKR-1, cell, ligand, MIP-3-alpha, RATTNF, COVID-19 Virus Infection, Hypoxemic Respiratory, severe acute respiratory syndrome coronavirus 2, Bone Marrow-Derived Macrophage, MIP-1alpha-R, AI847422, SARS-CoV-2 Infection, Crg2, clinical infection, Je, DmelCG12919, Sequencing, Bone Marrow-Derived, dTAF250, COVID-19 Virus, darth, SCYA3, ATGRP8, Transitional Epithelial Cells, SCYA2, Sigje, Chronic, Scya2, Scya3, Sequence Analyses, Transitional, Squamous Cells, RNA, Coronavirus Disease 19, Hypoxemic Respiratory Failures, 2019 Novel Coronavirus, beta-CoV, RNA Sequence Determinations, xtnf, disorders, Chronic Lung Injury, BG:DS00004.13, SARS-CoV-2 Infections, Granulocyte Chemotactic Peptide-Interleukin-8, Lymphocyte-Derived Neutrophil-Activating Peptide, Cell, dTAF230, dt1, COVID-19 Virus Disease, Cmkbr5, IP10, Monocyte-Derived, Severe Acute Respiratory Syndrome Coronavirus 2, Cmkbr1, Cuboidal Glandular Epithelial Cells, weche, Ventilatory, TAF[[II]]250/230, condition, Columnar Glandular Epithelial Cells, AI323594, epitheliocyte, Macrophage, Taf[[II]]250, 2019 Novel, betacoronavirus, RGD1560259, Macrophages, IFI10, Monocyte-Derived Neutrophil-Activating Peptide, GR-RBP8, MCP1, COVID-19 Pandemics, COVID-19 Pandemic, Ifi10, T24D18_5, IRX4, Anionic Neutrophil-Activating, Bone Marrow-Derived Macrophages, Macrophage Derived, Severe, COVID 19, T22F8.160, Epithelial Cell, Exodus, Scyb15, Infestations and Infections, Lymphocyte-Derived, Acute Hypercapnic Respiratory Failure, 2019 novel coronavirus, Scyb10, Virus Disease, 2019 nCoV Disease, IL-1, diseases, Neutrophil-Activating Peptide, ATCRR1, 2019-nCoV Disease, IL-8, AA408052, Novel Coronavirus, Monocyte-Derived Macrophage, Virus, diseases and disorders, xtnf-alpha, COVID 19 Pandemic, MIP-1-alpha, CXCL8 Chemokines, Immune Processes, Immune Responses, human disease, LARC, Determination, regg1, MIP1-alpha, Coronavirus Disease-19, Lung Injury, LD78ALPHA, acute and chronic respiratory failure, lungkine, il1b-A, CCR1, ASS, CKb4, Immune, HCA1, Respiratory, Macrophage-Derived Chemotactic Factor, Hypercapnic Acute Respiratory Failure, glycine-rich RNA-binding protein 8, SMC-CF, respiratory epithelial cell, Transitional Epithelial Cell, AM4-7, Process, CRG-2, COVID-19 Viruses, Adenomatous, Lung Injuries, mob-1, 2019 Novel Coronavirus Disease, ATCCR1, TAFII-250, TAF250/230, Transitional Epithelial, CCR5, Determinations, GDCF-2, PAS14, COVID19 Viruses, TAFII250, epithelial, Diseases, tnf-alpha, Coronavirus, COVID-19 Virus Infections, MIP1aR, Adenomatous Epithelial Cell, Squamous Cell, Anionic Neutrophil Activating Peptide, RANTES-R, cold, Coronavirus Disease 2019 Virus, CCCKR5, Anionic, Hypoxemic, Chemotactic Factor, CCR-5, TNFalpha, Mip-1a-R, BcDNA:RH51659, CCR-1, CG17603, TAF[[II]], cinnamoyl coa reductase 1, disease, Patient, SR3-5, NAP1, 2019 Novel Coronavirus Infection, Chemotactic Peptide-Interleukin-8, Interferon, mMage-e1, HIV-1 fusion coreceptor, Chemokines, COVID19, other disease, INP10, d230, TNF-alpha, MIP-1a, NAP-1, Hypercapnic Respiratory, Monocyte Derived Macrophages, COVID-19 Virus Diseases, dTAFII250, Lymphocyte Derived, Glandular Epithelial, circadian rhythm, EfW1, G0S19-1, Failure, TNF-a, CAT1, Depressions, Squamous Epithelial Cells, Vaping Product Use Associated Lung Injury, dmTAF1, Taf230, Il-1b, Ventilatory Depression, SARS CoV 2 Infection, Chronic Lung Injuries, E Cigarette or Vaping Product Use Associated Lung Injury, Squamous Epithelial, MIP1A, IL-1B, TAF250, 2019 Novel Coronaviruses, Epithelial, Taf200, HAF3, Viruses, MIP-3a, Respiratory Failure, IL-1beta, Wuhan Seafood Market Pneumonia Virus, chronic respiratory failure, Il8, Taf1p, HM145, 2010305L05Rik, Ect1, Interleukin 8, non-neoplastic, Chemokine CXCL8, Infestation and Infection, Immune Response, RNA Sequence Analyses, Epithelial Cells, Clients, MIP1-(a), UNQ868/PRO1885, Vaping Product Use-Associated Lung Injury, RNA Sequencing, disorder, IL8, TAF, Immune Process, Squamous Epithelial Cell, SARS Coronavirus 2 Infection, Neutrophil, Glandular Epithelial Cell, Wuhan Coronavirus, AI323804, CXCL8, Disease, TAF[[II]]250, LD78 receptor, LECT, CINNAMOYL COA REDUCTASE, GCP-1, Alpha-dystrobrevin-associated MAGE Protein, CMKBR5, gIP-10, ggr, Hypercapnic, l(3)84Ab, CRINKLY4 related 1, CMKBR1, medical condition, Monocyte Derived, LUCT, Client, GCP1, Peptide, 2019-nCoV Infection, tnfsf2, p230, acute-on-chronic respiratory failure, Infection, Neutrophil Activating Peptide, TFIID, IRREGULAR XYLEM 4, CKR-5, Disease 2019, TAF[[II]]230, airway epithelial cell, Macrophage-Derived, Pulmonary Injuries, Hypercapnic Respiratory Failures, Glandular Epithelial Cells, acute respiratory failure, Bone Marrow Derived Macrophages, GLC2, TAF[II]250, Wuhan, SPBC365.17, CKR-1, SARS-coronavirus 2, Injuries, Respiratory Depression, DmelCG17603, Mip1a, RNA Sequence Analysis, Response, Egr, Hypercapnic Respiratory Failure, COVID 19 Virus, T24D18.5, Tnfsf1a, MIP3A, TAF1"],"additional_accession":[]},"is_claimable":false,"name":"ena-DATASET-DKFZ-03-08-2020-18:14:14:560-2122 - samples","description":"To investigate the immune response and mechanisms associated with severe COVID-19, we performed single-cell RNA-seq on nasopharyngeal and bronchial samples from 19 clinically well-characterized patients with moderate or critical disease and from 5 healthy controls. We identified airway epithelial cell types and states vulnerable to SARS-CoV-2 infection. In COVID-19 patients, epithelial cells showed an average threefold increase in expression of the SARS-CoV-2 entry receptor ACE2, which correlated with interferon signals by immune cells. Compared with moderate cases, critical cases exhibited stronger interactions between epithelial and immune cells, as indicated by ligandÃ¢Â€Â“receptor expression profiles, and activated immune cells , including inflammatory macrophages expressing CCL2, CCL3, CCL20, CXCL1, CXCL3, CXCL10, IL8, IL1B and TNF . The transcriptional differences in critical cases compared with moderate cases likely contribute to clinical observations of heightened inflammatory tissue damage, lung injury and respiratory failure. Our data suggest that pharmacologic inhibition of the CCR1 and/or CCR5 pathways may suppress immune hyperactivation in critical COVID-19.","dates":{"updated":"2020-08-05 10:41:32"},"accession":"EGAD00001006339","cross_references":{"TAXONOMY":["9606"],"pubmed":["32591762"],"OLS":["MONDO_0100096"],"EGA":["EGAC00001001627","EGAS00001004481"]}}